Penumbra jumps on Boston Scientific's $14.5 billion buyout deal

Boston Scientific

15/01/2026 13:26

Updates

** Shares of medical equipment maker Penumbra PEN.N rise 13.6% to $356 premarket

** Boston Scientific says it will buy Penumbra in a deal valued at about $14.5 billion

** The transaction values each Penumbra share at $374, a premium of 19.3% to the stock's last close

** Boston Scientific BSX.N falls 4.10% to $89.90 premarket

** The deal is expected to be completed later this year

** BSX shares rose 6.75%, PEN rose 29.6% in 2025

 (Reporting by Christy Santhosh)

 ((Christy.Santhosh@thomsonreuters.com))